Literature DB >> 11309290

Cloning and characterization of human adenosine 5'-triphosphate-binding cassette, sub-family A, transporter 2 (ABCA2).

B Vulevic1, Z Chen, J T Boyd, W Davis, E S Walsh, M G Belinsky, K D Tew.   

Abstract

We have isolated the full-length cDNA for human ATP-binding cassette, sub-family A, member 2 transporter (ABCA2). The ORF of this cDNA encodes a protein consisting of 2436 amino acids with apparent molecular weight of M(r) 270,000. Accordingly, ABCA2 is the largest known mammalian ABC transporter described thus far. Analysis of mRNA expression levels indicated that ABCA2 is highest in human brain and has a broad expression pattern in a panel of tumor cell lines. Using specific antibodies to ABCA2 and various organelle marker proteins, ABCA2 was found to colocalize with the lysosomal/endosomal marker LAMP1, forming discrete, punctate intracellular vesicles. In ABCA2-transfected cells, the transporter also colocalized with a fluorescently labeled steroid analogue, estramustine. The sequestration of the steroid into the lysosomal/endosomal compartment indicates a potential substrate specificity for ABCA2. Furthermore, the presence of a lipocalin signature motif in the ABCA2 sequence suggests a possible broad role for this protein in the transport of steroids, lipids, and related molecules.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309290

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

Review 1.  The ABCA subfamily--gene and protein structures, functions and associated hereditary diseases.

Authors:  Christiane Albrecht; Enrique Viturro
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

2.  The ATP-binding cassette transporter-2 (ABCA2) regulates cholesterol homeostasis and low-density lipoprotein receptor metabolism in N2a neuroblastoma cells.

Authors:  Warren Davis
Journal:  Biochim Biophys Acta       Date:  2011-07-23

3.  ABCA2 transporter deficiency reduces incidence of TRAMP prostate tumor metastasis and cellular chemotactic migration.

Authors:  Jody T Mack; Kristi L Helke; Gabrielle Normand; CoDanielle Green; Danyelle M Townsend; Kenneth D Tew
Journal:  Cancer Lett       Date:  2010-10-30       Impact factor: 8.679

4.  Characterization of the ATPase activity of human ATP-binding cassette transporter-2 (ABCA2).

Authors:  Vladimir Beljanski; Athena Soulika; Jody M Tucker; Danyelle M Townsend; Warren Davis; Kenneth D Tew
Journal:  In Vivo       Date:  2005 Jul-Aug       Impact factor: 2.155

5.  The ATP-Binding Cassette Transporter-2 (ABCA2) Overexpression Modulates Sphingosine Levels and Transcription of the Amyloid Precursor Protein (APP) Gene.

Authors:  Warren Davis
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

6.  "Skittish" Abca2 knockout mice display tremor, hyperactivity, and abnormal myelin ultrastructure in the central nervous system.

Authors:  Jody T Mack; Vladimir Beljanski; Athena M Soulika; Danyelle M Townsend; Carol B Brown; Warren Davis; Kenneth D Tew
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

Review 7.  ATP-binding cassette transporter-2 (ABCA2) as a therapeutic target.

Authors:  Warren Davis; Kenneth D Tew
Journal:  Biochem Pharmacol       Date:  2017-12-06       Impact factor: 5.858

Review 8.  The ATP-binding cassette transporter ABCA2 as a mediator of intracellular trafficking.

Authors:  J T Mack; V Beljanski; K D Tew; D M Townsend
Journal:  Biomed Pharmacother       Date:  2006-08-31       Impact factor: 6.529

9.  Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Amy Whitten; Adi L Tarca; Gaurav Bhatti; Sorin Draghici; Piya Chaemsaithong; Jezid Miranda; Sonia S Hassan
Journal:  J Perinat Med       Date:  2013-09-01       Impact factor: 1.901

10.  Ablation of the ATP-binding cassette transporter, Abca2 modifies response to estrogen-based therapies.

Authors:  Jody T Mack; Carol B Brown; Tracy E Garrett; Joachim D Uys; Danyelle M Townsend; Kenneth D Tew
Journal:  Biomed Pharmacother       Date:  2012-07-02       Impact factor: 6.529

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.